You’ve probably noticed how fast our industry is evolving. Just when you think you’ve mastered all the essential marketing ...

Investing.com -- Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ: EYPT) fell 21% today, diverging from the company's recent announcement of positive results from the Phase 2 VERONA clinical ...

The visual representations make complex data easily ... cater to more experienced traders seeking efficient execution. Stock Market Guides is tailored for beginners, offering simple and easy ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

We recently published a list of 9 Best Augmented Reality Stocks to Invest in Under $10. In this article, we are going to take ...

Despite these positive outcomes, EyePoint's stock experienced a sharp decline. Cantor Fitzgerald analyst Jennifer Kim commented on the market reaction, stating, "There's nothing here that makes us ...

The artificial intelligence landscape is experiencing a seismic shift, with Chinese technology companies at the forefront of ...

Pinterest Inc. (PINS) stock soared 19% on Friday after posting strong revenue, EBITDA, and free cash flow (FCF) results. Is it time to buy? Based on its guidance and analysts' projections, Pinterest's ...

Why is everyone losing money and till when will this phase continue. More so what are the prime reasons for this downfall.

today announced Digital Domain Holdings Limited (Hong Kong Stock Exchange: 547; OTCQX: DDHLY), a global leader in visual effects and transformative experiences, has qualified to trade on the OTCQX® ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm neutral on OPT stock.